<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(Suppl 2)</volume><submitter>Pascal H</submitter><journal>Annals of oncology : official journal of the European Society for Medical Oncology</journal><pagination>ii78-ii79</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984058</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>P-272The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)</pubmed_title><pmcid>PMC4984058</pmcid><pubmed_authors>Louis K</pubmed_authors><pubmed_authors>Philip P</pubmed_authors><pubmed_authors>Alberto S</pubmed_authors><pubmed_authors>Jill L</pubmed_authors><pubmed_authors>Pascal H</pubmed_authors><pubmed_authors>Fabienne P</pubmed_authors><pubmed_authors>Eric T</pubmed_authors><pubmed_authors>Fernando R</pubmed_authors><pubmed_authors>Scot D</pubmed_authors><pubmed_authors>Thomas N</pubmed_authors><pubmed_authors>Luis M</pubmed_authors><pubmed_authors>Beatriz G</pubmed_authors><pubmed_authors>Edward K</pubmed_authors><pubmed_authors>Venu B</pubmed_authors><pubmed_authors>Jamil A</pubmed_authors><pubmed_authors>Jack S</pubmed_authors></additional><is_claimable>false</is_claimable><name>P-272The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2025-04-26T20:34:07.963Z</modification><creation>2025-04-06T16:26:14.851Z</creation></dates><accession>S-EPMC4984058</accession><cross_references/></HashMap>